Page URL:

US announces genetic test database

29 March 2010
Appeared in BioNews 551

The US National Institute of Health (NIH) has announced it plans to create a public Genetic Testing Registry (GTR). The database will contain information submitted voluntarily by genetic test providers. It aims to improve the levels of information accessible to consumers, researchers and healthcare providers, about the availability, validity and clinical usefulness of genetic tests. According to the NIH, there are more than 1,600 genetic tests available to patients and consumers, but there is no single public resource that provides detailed information about them.

'The need for this database reflects how far we have come in the last 10 years', said NIH Director Dr Francis Collins. 'The registry will help consumers and health care providers determine the best options for genetic testing, which is becoming more and more common and accessible'.

Key functions of the GTR will include encouraging providers of genetic tests to enhance transparency by publicly sharing information and providing a reliable resource for the public, allowing them to locate laboratories that offer particular tests. Furthermore, since the underlying goal of the database is to advance research, the GTR will provide an invaluable data-sharing facility for research and new scientific discoveries.

The actual database will be housed at the NIH and will be overseen by Dr Collins. 'Our combined expertise in biomedical research and managing such large databases makes NIH the ideal home for the registry', said Dr Collins.

In a statement, an NIH spokesperson said they 'will engage with stakeholders — such as genetic test developers, test kit manufacturers, health care providers, patients, and researchers — for their insights on the best way to collect and display test information' and that they would also seek the advice of other government agencies such as the Food and Drug Administration (FDA). The NIH have not yet said how much the database will cost to develop or maintain, but have confirmed that the National Center for Biotechnology Information will be responsible for its development, and that it is expected to be 'available in 2011'.

The NIH's plans have been well received, and the Genetic Alliance, together with the Coalition for 21st Century Medicine, hailed the GTR as 'a wonderful step forward for genetic testing and the integration of genetics into medicine'.

There is no equivalent database in the UK, or any plans to develop one, despite the UK's PHG Foundation, which campaigns for equal access to innovations in genomics and biomedicine, having repeatedly highlighted the need for such a system.

Genetic test registry
Nature |  24 March 2010
New Genetic Testing Registry announced
PHG Foundation |  19 March 2010
NIH Wants to Hear About Genetic Tests
Science Insider |  18 March 2010
Thank Goodness NIH's Genetic Testing Registry Will Be Voluntary
GenomeWeb |  18 March 2010
8 October 2012 - by Dr Lucy Freem 
A streamlined method to find disease-causing single gene mutations has been developed to aid diagnosis of critically ill infants...
17 January 2011 - by Rosie Beauchamp 
A recent study suggests American consumers would be prepared to pay on average up to $600 for a predictive genetic test where no direct treatment is available....
17 May 2010 - by Rosemary Paxman 
Personal genetic testing kits are to be sold in US pharmacies for the first time, US biotech firm Pathway Genomics has announced...
9 July 2009 - by MacKenna Roberts 
When giving evidence to the Lords' inquiry into genomic medicine, Health Minister Dawn Primarolo estimated that the vast potential benefits of genomic medicine will not largely be seen by patients for at least a decade. The House of Lords Science and Technology Committee respectfully but conclusively disagrees in its report on Genomic Medicine, published 7 July 2009. Lord Patel who chaired the inquiry surmised; 'Genomic medicine will clearly have a huge impact on health provision and the NHS
12 August 2008 - by MacKenna Roberts 
Government officials in Australia have held a joint public meeting to discuss the dangers of the burgeoning but largely unregulated direct-to-consumer genetic testing market. Chair Professor Ron Trent from the National Health and Medical Research Council, Human Genetics Advisory Committee (HGAC) and Professor David Weisbrot, the president...
30 June 2008 - by MacKenna Roberts 
The California state government issued 'cease-and-desist' letters two weeks ago to 13 'direct-to-consumer' genetic-testing companies demanding they immediately stop selling genetic tests to California residents and provided them until last Tuesday, 23 June, to prove to authorities that they had complied with state and federal regulations or...
7 April 2008 - by Katy Sinclair 
By Katy Sinclair: The US Genetics and Public Policy Center at John Hopkins University, has called for increased regulation of direct to consumer genetic tests by the Food and Drug Administration (FDA). The recommendation follows a policy analysis, the results of which were published in the journal Science last week...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.